Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Itamar Medical Acquires Technology and Assets of Spry Health
Itamar Medical Ltd.January 12, 2021 GMT Enables Itamar to leverage Spry’s existing FDA-cleared technology to bring to market the first device for continuous remote patient monitoring (RPM) of sleep apnea Adds the capability to monitor the longer-term accumulated disease burden of sleep apnea to complement the single night diagnostics commonly used today, including the Company’s existing WatchPAT™ device
Paves the way for an end-to-end digital care pathway that can further expand Itamar’s presence in obstructive sleep apnea (OSA) diagnostics and advance support for chronic cardiovascular and COPD disease management
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Itamar Medical Announces Preliminary Revenue Results for Fourth Quarter and Full Year 2020
Itamar Medical Ltd.January 7, 2021 GMT
- 2020 Fourth Quarter
- 2020 Fiscal Year Revenues Expected to Increase Approximately 31% to $40.8-$41.1 million -
CAESAREA, Israel, Jan. 07, 2021 (GLOBE NEWSWIRE) Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported preliminary unaudited revenue results for the fourth quarter and full year ended December 31, 2020.
Preliminary Fourth Quarter 2020 Revenue: